These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11040341)

  • 1. Lack of tolerance to motor stimulant effects of a selective adenosine A(2A) receptor antagonist.
    Halldner L; Lozza G; Lindström K; Fredholm BB
    Eur J Pharmacol; 2000 Oct; 406(3):345-54. PubMed ID: 11040341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats.
    Pinna A; Fenu S; Morelli M
    Synapse; 2001 Mar; 39(3):233-8. PubMed ID: 11284438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors.
    El Yacoubi M; Ledent C; Ménard JF; Parmentier M; Costentin J; Vaugeois JM
    Br J Pharmacol; 2000 Apr; 129(7):1465-73. PubMed ID: 10742303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-sensitization between the motor activating effects of bromocriptine and caffeine: role of adenosine A(2A) receptors.
    Fenu S; Cauli O; Morelli M
    Behav Brain Res; 2000 Sep; 114(1-2):97-105. PubMed ID: 10996051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of SCH 58261, an adenosine A(2A) receptor antagonist, on quinpirole-induced turning in 6-hydroxydopamine-lesioned rats. Lack of tolerance after chronic caffeine intake.
    Popoli P; Reggio R; Pèzzola A
    Neuropsychopharmacology; 2000 May; 22(5):522-9. PubMed ID: 10731627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats.
    Fenu S; Pinna A; Ongini E; Morelli M
    Eur J Pharmacol; 1997 Feb; 321(2):143-7. PubMed ID: 9063681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats.
    Corsi C; Pinna A; Gianfriddo M; Melani A; Morelli M; Pedata F
    Eur J Pharmacol; 2003 Mar; 464(1):33-8. PubMed ID: 12600692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration.
    Karcz-Kubicha M; Antoniou K; Terasmaa A; Quarta D; Solinas M; Justinova Z; Pezzola A; Reggio R; Müller CE; Fuxe K; Goldberg SR; Popoli P; Ferré S
    Neuropsychopharmacology; 2003 Jul; 28(7):1281-91. PubMed ID: 12700682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transducing system operated by adenosine A(2A) receptors to facilitate acetylcholine release in the rat hippocampus.
    Rebola N; Oliveira CR; Cunha RA
    Eur J Pharmacol; 2002 Nov; 454(1):31-8. PubMed ID: 12409002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between adenosine and dopamine receptor antagonists with different selectivity profiles: Effects on locomotor activity.
    Collins LE; Galtieri DJ; Collins P; Jones SK; Port RG; Paul NE; Hockemeyer J; Müller CE; Salamone JD
    Behav Brain Res; 2010 Aug; 211(2):148-55. PubMed ID: 20211657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine, acting on adenosine A(1) receptors, prevents the extinction of cocaine-seeking behavior in mice.
    Kuzmin A; Johansson B; Zvartau EE; Fredholm BB
    J Pharmacol Exp Ther; 1999 Aug; 290(2):535-42. PubMed ID: 10411560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine A1 receptor blockade mimics caffeine's attenuation of ethanol-induced motor incoordination.
    Connole L; Harkin A; Maginn M
    Basic Clin Pharmacol Toxicol; 2004 Dec; 95(6):299-304. PubMed ID: 15569276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCH 58261 and ZM 241385 differentially prevent the motor effects of CGS 21680 in mice: evidence for a functional 'atypical' adenosine A(2A) receptor.
    El Yacoubi M; Ledent C; Parmentier M; Costentin J; Vaugeois J
    Eur J Pharmacol; 2000 Jul; 401(1):63-77. PubMed ID: 10915839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeine and a selective adenosine A2A receptor antagonist induce reward and sensitization behavior associated with increased phospho-Thr75-DARPP-32 in mice.
    Hsu CW; Chen CY; Wang CS; Chiu TH
    Psychopharmacology (Berl); 2009 Jun; 204(2):313-25. PubMed ID: 19169672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine.
    Lindskog M; Svenningsson P; Pozzi L; Kim Y; Fienberg AA; Bibb JA; Fredholm BB; Nairn AC; Greengard P; Fisone G
    Nature; 2002 Aug; 418(6899):774-8. PubMed ID: 12181566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease.
    Chen JF; Xu K; Petzer JP; Staal R; Xu YH; Beilstein M; Sonsalla PK; Castagnoli K; Castagnoli N; Schwarzschild MA
    J Neurosci; 2001 May; 21(10):RC143. PubMed ID: 11319241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCH 58261 (an adenosine A(2A) receptor antagonist) reduces, only at low doses, K(+)-evoked glutamate release in the striatum.
    Pintor A; Quarta D; Pèzzola A; Reggio R; Popoli P
    Eur J Pharmacol; 2001 Jun; 421(3):177-80. PubMed ID: 11516434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine A1 and A2A receptor antagonists stimulate motor activity: evidence for an increased effectiveness in aged rats.
    Popoli P; Reggio R; Pèzzola A; Fuxe K; Ferré S
    Neurosci Lett; 1998 Jul; 251(3):201-4. PubMed ID: 9726378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A galpha(s) carboxyl-terminal peptide prevents G(s) activation by the A(2A) adenosine receptor.
    Mazzoni MR; Taddei S; Giusti L; Rovero P; Galoppini C; D'Ursi A; Albrizio S; Triolo A; Novellino E; Greco G; Lucacchini A; Hamm HE
    Mol Pharmacol; 2000 Jul; 58(1):226-36. PubMed ID: 10860945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated treatment with adenosine A1 receptor agonist and antagonist modifies the anticonvulsant properties of CPPene.
    De Sarro G; Donato Di Paola E; Falconi U; Ferreri G; De Sarro A
    Eur J Pharmacol; 1996 Dec; 317(2-3):239-45. PubMed ID: 8997606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.